Epilepsy, characterized by recurrent seizures, affects 1% of the population. More than 30% of patients are drug-resistant, a significant burden to their lives. New innovative ways to treat the disorder are needed. Cannabidiol (CBD), a nonpsychoactive compound derived from the cannabis plant, has been shown to be a promising new treatment for epilepsy. In collaboration with Avicanna, we will test the antiepileptic effects of CBD and other cannabinoids alone and in combination with common anticonvulsant drugs on both mouse and human brain tissue. In addition, we will also develop a high-throughput multi-well brain slice recording system.
Yasaman Javadzadeh;Alexandra Santos
Engineering - biomedical
Professional, scientific and technical services
University of Toronto
Find the perfect opportunity to put your academic skills and knowledge into practice!Find Projects
The strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.